MedPath

To Study the effects of Unani Formulation Joshanda Aftimoon in patients with Generalized Anxiety Disorder

Phase 2
Conditions
Health Condition 1: F411- Generalized anxiety disorder
Registration Number
CTRI/2023/03/050663
Lead Sponsor
Central Council for Research in Unani Medicine New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Clinically diagnosed patients of Izterab-i-Nafsani Umoomi

Patients in age group of 18 to 65 years

Irrespective of gender

Patients, who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily.

Exclusion Criteria

Panic disorder, Obsessive Compulsive disorder, Post-traumatic stress disorder,etc.

Patients below 18 years and above 65 years.

History of substance abuse : Caffeine, Alcohol, Drug intoxication.

Patient who fails to follow up.

Patient who fails to give written consent.

Known cases of Hyperthyroidism, Cardiovascular disease, Renal disease and Liver disease.

Pregnant and lactating mother.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Hamilton Anxiety Rating Scale (HAM-A)24 <br/ ><br>2.Anxiety State Test (AST)- State-Trait Anxiety Inventory (STAI)23 <br/ ><br>3.Beck Anxiety Inventory (BAI)32Timepoint: 40 Days
Secondary Outcome Measures
NameTimeMethod
1.Vegetative manifestations (increased heart rate, diaphoresis, tremor, or dry mouth) <br/ ><br>2.Symptoms in the chest or abdomen (respiratory symptoms, feeling of tightness, chest pain, abdominal discomfort) <br/ ><br>3.Mental symptoms (dizziness, derealization, fear of losing control, fear of dying) <br/ ><br>4.General symptoms (hot or cold flashes, paresthesias) <br/ ><br>5.Symptoms of tension (muscle tension, agitation, foreign-body sensation in throat) <br/ ><br>6.Other nonspecific symptoms(exaggerated startle response, lack of concentration, irritability, difficulty falling asleep)Timepoint: 40 Days
© Copyright 2025. All Rights Reserved by MedPath